Kymera Therapeutics, Inc.
CRBN LIGANDS AND USES THEREOF
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Status:
Application
Type:
Utility
Filling date:
21 Sep 2018
Issue date:
3 Dec 2020